NON-RENAL CELL CARCINOMA OF KIDNEY

NON-RENAL CELL CARCINOMA OF KIDNEY was reported 23 times

NON-RENAL CELL CARCINOMA OF KIDNEY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TOPOTECAN HYDROCHLORIDE 1 0.0004
1 GEMCITABINE HYDROCHLORIDE 15 0.0003
2 PEGFILGRASTIM 2 0.0002
3 TOPOTECAN 1 0.0002
4 ERLOTINIB HYDROCHLORIDE 2 0.0002
5 ZOLMITRIPTAN 1 0.0001
6 CISPLATIN 10 0.0001
7 EVEROLIMUS TABLETS 2 0.0001
8 DOXORUBICIN 10 0.0001
9 IFOSFAMIDE FOR INJECTION 2 0.0001
10 CRIZOTINIB 1 0.0001
11 FILGRASTIM 2 0.0001
12 PACLITAXEL 5 0.0000
13 EVEROLIMUS 2 0.0000
14 CARBOPLATIN 5 0.0000
15 IXAZOMIB 1 0.0000
16 SUNITINIB MALATE 1 0.0000
17 BEVACIZUMAB 3 0.0000
18 IPILIMUMAB 1 0.0000
19 BORTEZOMIB 2 0.0000
20 CAPECITABINE 2 0.0000
21 FINGOLIMOD HCL 1 0.0000
22 METHOTREXATE SODIUM 4 0.0000
23 LEVETIRACETAM 1 0.0000
24 CYCLOPHOSPHAMIDE FOR INJECTION 1 0.0000
25 CYCLOPHOSPHAMIDE 1 0.0000
26 IBUPFROFEN 1 0.0000
27 IBUPROFEN TABLETS USP, 200MG 1 0.0000
28 IBUPROFEN ORAL 1 0.0000
29 IBUPROFEN CAPSULES 200 MG 1 0.0000
30 DENOSUMAB 1 0.0000
31 ALPRAZOLAM 1 0.0000
32 OXYCODONE HYDROCHLORIDE 1 0.0000
33 IBUPROFEN 1 0.0000
34 ACETAMINOPHEN 1 0.0000